Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	58.30	286.91	181.24
Graham Fair Price	19.20	0.85	0.72
PEG	-46.40	2.98	-5.56
Price/Book	-15.09	2.45	2.89
Price/Cash Flow	1901.47	2833.19	-141.56
Prices/Earnings	-54.95	198.50	440.58
Price/Sales	-28.09	2.57	3.57
Price/FCF	1901.47	2833.19	-141.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-25.98	0.05	0.07
Operating Margin	-37.12	< 0.005	< 0.005
ROA	86.56	< 0.005	< 0.005
ROE	< 0.005	< 0.005	88.45
ROIC	< 0.005	< 0.005	49.69
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.01	-94.08
Dividends QOQ	-0.67	-0.78	-17.14
EBIT QOQ	-0.34	-0.28	17.23
EPS QOQ	-0.79	0.67	-15.94
FCF QOQ	-2.04	1.04	-48.88
Revenue QOQ	-0.10	0.15	41.74
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	28.48	24.68	-13.35
Days Sales Outstanding (DSO)	101.88	88.53	-13.10
Inventory Turnover	3.16	3.65	15.40
Debt/Capitalization	0.33	0.34	1.93
Quick Ratio	1.30	1.28	-1.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.73	3.23	-13.17
Cash	0.87	0.66	-24.53
Capex	-0.02	< 0.005	81.09
Free Cash Flow	-0.08	< 0.005	-96.32
Revenue	3.02	3.09	2.53
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.61	1.59	-0.94
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.06	31.90	111.87
Naive Interpretation	Member

06 - Financial Health · Weak

Rating